News
-
Alliance
C4U and Sumitomo Dainippon Pharma enter into Joint Research and Alliance Agreement
-
Alliance
C4U and Asahi Kasei have entered into the agreement for the joint research and development of a nucleic acid detection kit utilizing CRISPR-Cas3.
-
Alliance
C4U have started a joint research on CRISPR-Cas3 delivery system using lipid nanoparticles with Laboratory for Molecular Design of Pharmaceutics, Faculty of Pharmaceutical Sciences, Hokkaido University.
-
Alliance
C4U and TAUNS Laboratories enter into Joint Development and Commercialization Agreement
-
Information
A novel CRISPR diagnostic, named “CONAN” method, developed by Prof. Tomoji Mashimo, was featured in the Asahi Shinbun.
-
R&D
The paper was published in Human Genetics.
-
R&D
The paper was published in medrxiv.
-
Alliance
C4U and Noile-Immune Biotech Partnership on PRIME Allogeneic CAR-T Cell Therapy Using CRISPR/Cas3 Genome Editing Technology
-
R&D
The paper was published in nature communications.